Defunct Company
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
1,512
NCT00133913
Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer
Phase: N/A
Role: Lead Sponsor
Start: Mar 31, 2004
Completion: Jan 31, 2009
NCT00133900
Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy
Start: Dec 31, 2004
Completion: Feb 28, 2009
NCT00208546
Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
Phase: Phase 3
Role: Collaborator
Start: Jun 30, 2005
Completion: Dec 31, 2009